Cancer Policy Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend” December 05, 2025Vol.51 No.44By Jacquelyn Cobb
Cancer Policy FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies December 05, 2025Vol.51 No.44By Jacquelyn Cobb
Cancer Policy Vaccine skeptic installed as CDC’s new second-in-command December 05, 2025Vol.51 No.44By Claire Marie Porter
Cancer Policy CMS cuts deal on four oncology drugs under Medicare December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Medicare Part B premiums expected to rise almost 10% in 2026 December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Hospitals sue to block CMS 340B drug rebate pilot December 05, 2025Vol.51 No.44By Sara Willa Ernst
Cancer Policy Trump administration puts new restrictions on federal student loan borrowing December 05, 2025Vol.51 No.44By Jacquelyn Cobb
In Brief Paradigm Health acquires Flatiron Health’s clinical research business December 05, 2025Vol.51 No.44
In Brief Ben Ho Park, Sara Tolaney to receive awards at 2025 San Antonio Breast Cancer Symposium December 05, 2025Vol.51 No.44
